The risks and benefits of surveillance colonoscopy in elderly patients have not been well characterized. OBJECTIVE To investigate the relative impact of surveillance colonoscopy in elderly patients compared with a reference cohort. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study from 2001 through 2010 of patients 50 years and older undergoing surveillance colonoscopy for a history of colorectal cancer (CRC) or adenomatous polyps at an integrated health care system in southern California. Patients were followed up from the surveillance examination until CRC diagnosis, death, disenrollment, IBD diagnosis, or study end date (December 31, 2010).
C olorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States. The incidence of CRC increases with age. Current evidence-based guidelines recommend screening for persons at average risk starting at the age of 50 years. The American College of Physicians guideline recommends against further screening for adults after age 75 years; however, the US Preventative Services Task Force guideline recommends additional individualized decision making about colorectal cancer screening between ages 75 and 85 years. 1, 2 Colonoscopy is universally recommended for surveillance of individuals with a personal history of adenomatous polyps or CRC. 3, 4 However, current guidelines have not addressed the issue of when, if ever, surveillance should be stopped. 5, 6 To date, few studies have addressed surveillance colonoscopy in the elderly population (age ≥75 years). 3, 5, 7 This issue is of increasing importance because the size of this age cohort is expected to increase in the coming years. 3, 8 Studies have examined the risks of having colonoscopies in elderly patients, [9] [10] [11] [12] [13] [14] [15] [16] [17] as well as the overall benefits of continuing surveillance following polypectomy or resection of a CRC. [18] [19] [20] [21] [22] [23] [24] However, elderly patients represent a unique patient population with specific health care needs, and it is not yet established at which point risk of a colonoscopy might potentially outweigh expected benefits of ongoing surveillance.
The objective of this study was to determine how the risks and benefits of surveillance colonoscopy vary between the elderly and younger patients. We characterized the benefit of surveillance examination as the incidence of CRC detected and characterized risk as the incidence of hospitalizations within 30 days of colonoscopy.
Methods

Study Design, Setting, and Participants
This retrospective cohort study from 2001 through 2010 was approved by the institutional review board of Kaiser Permanente Southern California. Kaiser Permanente Southern California (KPSC) is an integrated health care system that provides comprehensive health services for approximately 3.6 million residents of southern California. KPSC also provides care for Medicare patients through Medicare Advantage. The population served by KPSC is socioeconomically diverse and broadly representative of the racial/ethnic groups living in southern California. Members enroll through the Kaiser Foundation Health Plan for prepaid health care insurance, including pharmaceutical benefits. KPSC is one of Kaiser Permanente's largest regions, which provides care at 15 hospitals and more than 200 medical offices by a partnership of over 6000 physicians who comprise the entire range of medical specialists including 13 gastroenterology groups.
The study population included individuals who underwent surveillance colonoscopy during 2001 through 2010. All individuals 50 years and older at the time of the procedure with a prior diagnosis of CRC (V10.05) or adenomatous polyps (V12.72) were potentially eligible for study inclusion. Surveillance colonoscopy procedures were identified by combining Current Procedural Terminology (CPT) for colonoscopy procedure and International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes for history of CRC or polyp. Specifically, both CPT and ICD-9-CM V codes had to be assigned at the time of the procedure. An index date was then determined by the earliest surveillance examination. Baseline clinical and demographic information was obtained dating back 1 year from the index date (for codes, see eAppendix 2 in the Supplement). Individuals with less than 1 year of enrollment prior to the index date and those with inflammatory bowel disease (IBD) were excluded from the study. After assembling the study population, the cohort was stratified into 2 groups: elderly surveillance cohort (defined as age ≥75 years) vs reference surveillance cohort (defined as age 50-74 years). See Figure 1 for a study diagram.
Study Outcomes and Measures
To identify new or recurrent CRC cases, we cross-referenced the unique medical record identifier of each patient with a prospectively maintained internal cancer registry. The registry contains data on all patients diagnosed or treated for a new cancer since 1988. Cancer case ascertainment in this registry has been validated with high sensitivity (>99%) because reporting of cancers is mandated under state law and abstracts of patients with cancer are sent to the State of California Cancer Registry and the National Cancer Institute Surveillance, Epidemiology and End Results (SEER) program. Patients were followed up from the surveillance examination until CRC diagnosis, death, disenrollment, IBD diagnosis, or study end date (December 31, 2010).
Potential risks associated with surveillance colonoscopy were measured as hospitalization within 30 days of outpatient surveillance colonoscopy. Adverse events leading to hospitalization were categorized as procedure related, other gastrointestinal disorder, and other causes based on individual medical record review of discharge diagnoses and discharge summaries. Procedure-related admissions included principal diagnosis of gastrointestinal tract hemorrhage, cardiac arrhythmia, or perforation. Admission related to gastrointestinal disorder or other nonprocedural-related, nongastrointestinal-related causes are provided in eTables 1 to 4 in the Supplement. 
Statistical Analysis
Summary Statistics and Demographics Means of quantitative variables, age, length of follow-up, and length of stay were compared between the elderly and reference cohorts using 2-sample t tests. For purpose of analysis, age was categorized into 50 to 74 years and 75 years and older and into 50 to 54, 55 to 59, 60 to 64, 65 to 69, 70 to 74, 75 to 79, 80 to 84, and 85 years and older. Sex, race/ethnicity, Charlson comorbidity score (categorized into 0, 1, 2, and ≥3), and risk factors for CRC (dichotomized into "0" and "1," with "0" meaning absence of risk factor) were compared using χ 2 tests or Fisher exact tests. All statistical tests were 2-sided, and P < .05 was considered significant. All analyses were conducted using SAS Enterprise Guide Version 4.3 (SAS Institute Inc).
CRC Incidence
We calculated CRC incidence density based on person-time at risk for each of the individual cohorts. To examine if CRC incidence varied with age, we first calculated a constant person-year incidence rate for the reference population (age <75 years) and elderly cohort (age ≥75 years) by dividing number of CRC cases by person-years of follow-up. Then we examined the CRC incidence more precisely by categorizing patients into 6 age groups (50-54, 55-59, 60-64, 65-69, 70-74, and ≥75 years). For each age group, we plotted a crude cumulative incidence curve using the Kaplan-Meier method and compared the curves using the log-rank test. We also performed multivariable Cox proportional hazards regression to assess age differences in incidence of CRC, adjusted for race/ethnicity, sex, personal history of CRC vs history of polyps, Charlson comorbidity score, and risk factors of CRC including family history of CRC or polyps, alcohol abuse (305.0X), tobacco use (305.1X, V15.82; includes current and history of tobacco use), nonsteroidal antiinflammatory drug use (V58.64), as well as obese and overweight status (278.X, persons with body mass index ≥25 [calculated as weight in kilograms divided by height in meters squared]). These variables were selected based on availability of ICD-9-CM codes to reduce potential confounders and include risk factors for CRC per literature review. 10, 25 Postprocedure Hospitalization For analysis of postprocedure hospitalization, we included patients with at least 30 days of follow-up after their surveillance examination. We calculated the incidence rate ratio of hospitalization following surveillance colonoscopy based on cumulative incidence of unplanned hospitalizations stratified by age. We compared the risk of postprocedure hospitalization within 30 days between age groups 75 years and older or 75 to 79, 80 to 85, and 85 years and older vs 50 to 74 years using logistic regression. We incorporated the same covariates in the logistic regression analysis as in the aforementioned Cox regression analysis. In addition to the overall rate of hospitalization, we calculated separate incidence rates for procedure-related and gastrointestinal complications, as well as all-cause hospitalizations.
Results
Study Population
A total of 27 763 subjects were identified after excluding 261 with IBD and 2259 without 1 year of prior enrollment (Figure 1) . Table 1 gives the characteristics of the study cohort. Over 82% (22 929) 
Incidence of CRC After Surveillance Examination
During a mean follow-up period of 4.3 years, a total of 373 CRCs were detected, 368 in the reference group and 5 among patients 75 years and older. Of the CRCs detected, 43 patients had a history of CRC compared with 330 patients with a history of polyp (see eTable 5 in the Supplement). Mean follow-up for the reference cohort was 53.4 months compared with 51.6 in the elderly cohort (P < .001).
The age-stratified incidence rates of CRC are summarized in the eFigure in the Supplement. With a total of 122 802.2 person-years of follow-up, the overall CRC incidence was 3.04 per 1000 person-years. The incidence among the elderly patients was lower at 0.24 per 1000 person-years compared with the incidence in the reference cohort of 3.61 per 1000 personyears (P < .001). This finding was consistent across both sexes (eTable 7 in the Supplement).
Kaplan-Meier Curve and Cox Regression Analysis
Cumulative incidence curves of CRC between the reference and elderly cohort are depicted in Figure 2 . There was a significantly lower incidence of CRC detected in the elderly cohort compared with the reference cohort (log rank, P < .001). Hazard ratios (HRs) from unadjusted and adjusted Cox regression models are summarized in Table 2 . The analysis included adjustment for race/ethnicity, sex, personal history of CRC vs history of polyps, Charlson comorbidity score, and CRC risk factors. The HR for CRC in the elderly cohort compared with the reference surveillance population was 0.06 (95% CI, 0.02-0.13). In addition to age, patients with Charlson score of 3 or greater were twice as likely to have CRC compared with patients with a Charlson score of 0 (HR, 1.97; 95% CI 1.42-2.73).
To examine how CRC incidence varied with age, another adjusted Cox regression analysis was performed with age categorized into 5-year age groups (50-54, 55-59, 60-64, 65-69, 70-74, and ≥75 years). The CRC incidence for the 75-year-and-older age group was significantly lower than the younger reference age group (50-54 years) (HR, 0.05; 95% CI, 0.02-0.13). All other age strata had similar CRC incidence when compared with the reference age group 
Hospitalization After Surveillance Colonoscopy
A total of 27 628 patients were included in the analysis of postsurveillance colonoscopy hospitalizations after excluding 135 who did not meet the 30-day enrollment criterion. A total of 711 patients (2.6%) were hospitalized within 30 days of surveillance examination. Higher hospitalization rate was noted among the elderly cohort than the reference cohort (3.8% [n = 527] and 2.3% [n = 184], respectively; P < .001). This finding was consistent across both sexes (eTable 6 in the Supplement).
Indications for hospitalization included procedurerelated complications (13.0%), gastrointestinal-related complications (33.0%), or other causes (30.1%) (eTable 1 in the Supplement). Individual breakdown of the cause for hospital- In multivariable logistic regression analysis, patients 75 years and older were at 28% higher risk of postprocedure hospitalization compared with those aged 50 to 74 years, independent of demographics and other known risk factors (OR, 1.28
[95% CI, 1.07-1.53]; P = .006). Charlson score of 3 or greater was independently associated with a 3-times higher risk for postprocedure hospitalization (OR, 3.75 [95% CI, 3.05-4.60]; P < .001) ( Table 3 ). The analysis included adjustment for the additional variables used in Cox regression analysis. In another similarly adjusted logistic regression, the elderly cohort was stratified into 3 age groups (75-79, 80-84, and ≥85 years) and compared with the younger reference cohort. The risk of hospitalization was highest in the 85-years-andolder age group. For age groups 75 to 79 years, 80 to 84 years, and 85 years and older, the ORs (95% CIs) were 1.22 (0.98-1.51) (P = .08); 1.34 (1.00-1.78) (P = .048); and 1.55 (0.99-2.43) (P = .055), respectively.
Discussion
We evaluated the incidence of CRC on surveillance colonoscopy as well as the frequency of postprocedural hospitalization in a cohort of 27 763 patients with a history of either CRC or adenomatous polyps. Overall, there was a lower incidence of CRC in the elderly cohort compared with the reference population undergoing surveillance examination. By contrast, the rate of postprocedure hospitalization was substantially higher in the elderly cohort. Age 75 years and older and a Charlson score of 2 or higher were independent risk factors for postprocedure hospitalization.
Determining the potential risk and benefits of surveillance colonoscopy in the elderly population is important because the size of this segment of the population is projected to double between 2012 and 2060. 8 Previous studies have demonstrated that increasing age can be associated with decreased physiological reserve. [26] [27] [28] This may in turn potentially increase the risk of surveillance colonoscopy among the elderly population. Meanwhile, the benefits of ongoing surveillance in this population have yet to be firmly established. Comparison between older (Ն75 years) vs younger (<75 years) cohorts found a statistically significant decrease in colorectal cancer (CRC) in the older cohort (log rank P < .001). The x-axis shows follow-up time in 24-month intervals, along with number of participants (age Ն75 or <75 years) that still remained at risk (or CRC free). Prior studies evaluating incidence of CRC in the elderly population have produced inconsistent findings.
Our study demonstrated a decrease in CRC during surveillance colonoscopy with increasing age. Incidence of CRC in our elderly cohort was 10 times less than the SEER data when examining the CRC incidence rate by age (≥75 years) for the year 2000-2011. 29 In a retrospective study by Khan et al, 11 it was found that increasing age was associated with increased risk of malignancy. However, no specification was made whether elderly patients in this study had undergone prior colonoscopy. In a study by Duncan et al, 30 diagnostic yield of malignancy was low in elderly patients (average age, 83 years) undergoing screening or surveillance examination. In contrast, others have reported a high yield of CRC and polyps. 23, 31 However, these studies included a wide range of age groups and, in particular, did not distinguish between surveillance or screening examinations. Literature review on posttreatment CRC recurrence also found high rates of CRC recurrence but only followed up patients for the first 1 to 2 years after curative surgical resection. 22, [32] [33] [34] This is unlike our study that examined surveillance colonoscopies over several years.
Our study of adverse events postsurveillance colonoscopy tracked similarly to prior studies evaluating colonoscopy in general. 9, 10, 13, [15] [16] [17] Of particular note, in a retrospective study by Kahi et al 10 that focused on persons 75 years or older, postprocedure mortality was increased among patients older than 75 years and increasing Charlson score. Another meta-analysis by Day et al 9 found higher adverse events in older patients (≥80 years). This study pooled incidence rates for adverse events in patients undergoing colonoscopy. In octogenarians, adverse events (per 1000 colonoscopies) included the following: cumulative gastrointestinal adverse event rate, 34.9 (95% CI, 31.9-38.0); gastrointestinal tract bleeding rate, 2.4 (95% CI, 1.1-4.6); and mortality rate, 0.5 (95% CI, 0.06-1.9). Our data of adverse events defined as postprocedure hospitalization within 30 days found a higher hospitalization rate among the elderly cohort compared with the younger cohort (3.8% [n = 527] and 2.3% [n = 184], respectively; P < .001) but included other causes of hospitalizations in addition to adverse gastrointestinal causes.
In the present study, increasing age (≥75 years) was associated with decreased CRC incidence on surveillance. There are several potential explanations for these findings. First, the decrease in CRC on surveillance with age may be because prior surveillance or screening was successful in removing potentially malignant lesions. Another possibility is that elderly patients may have been more likely to experience death from other comorbidities, as noted in our study and by other previous studies. 10, 12 In one study by Kahi et al, 10 41% of its elderly patients died of cardiac causes or extracolonic malignant conditions. 10 Our finding of increased hospitalizations associated with increasing age and Charlson comorbidity support the underlying theory that with increasing age, the physiologic reserve for elderly patients to tolerate the surveillance examination decreases. In addition, on individual hospital record review, the major procedure-related complication was gastrointestinal tract bleeding. While procedure related complications comprised only 13% of postprocedure hospitalizations, exacerbation of underlying comorbid illness was a major indication for unplanned admissions (63.1%). While not directly related to the procedure per se, exacerbation of underlying comorbidities may be a potential indirect consequence of invasive testing in this population.
Of note, our study also found that increasing comorbidity was associated with increased CRC incidence. Previous studies have evaluated the relationship between Charlson score and age in the CRC population. [35] [36] [37] These studies found higher comorbidity to be associated with increasing age. Higher comorbidity was also associated with poorer prognosis. We speculate that one reason increasing comorbidity was associated with higher CRC incidence may be attributed to a lower level of surveillance intensity, such that Abbreviations: CRC, colorectal cancer; NSAID, nonsteroidal anti-inflammatory drug; OR, odds ratio.
